Patents by Inventor Matthew V. Sennitt

Matthew V. Sennitt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for decreasing body weight using a somatostatin receptor agonist
    Patent number: 7662784
    Abstract: The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. A pharmaceutical/cosmetic composition comprises the somatostatin or somatostatin agonist. Such products are used to prepare such compositions for the reduction or body weight in a human or mammalian animal.
    Type: Grant
    Filed: November 29, 2005
    Date of Patent: February 16, 2010
    Assignee: Ipsen Pharma, S.A.S.
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
  • Somatostatin and somatostatin agonists for treating insulin insensitivity and Syndrome X
    Patent number: 7256174
    Abstract: The present invention relates to a method of treating insulin resistance or Syndrome X by administering a therapeutically effective amount of a somatostatin agonist or a pharmaceutical composition comprised of a somatostatin agonist to a patient suffering from insulin resistance or Syndrome X.
    Type: Grant
    Filed: February 18, 2003
    Date of Patent: August 14, 2007
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques, S.A.S.
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
  • Somatostatin and somatostatin agonists for decreasing body weight
    Patent number: 7034003
    Abstract: The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. A pharmaceutical/cosmetic composition comprises the somatostatin or somatostatin agonist. Such products are used to prepare such compositions for the reduction of body weight in a human or mammalian animal.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: April 25, 2006
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques, SAS
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
  • Method and compositions for treating hyperlipidemia and other conditions
    Patent number: 7026289
    Abstract: The present invention relates to a method of treating hyperlipidemia and to reducing triacylglycerols, glycerol and cholesterol in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to said patient. A pharmaceutical composition comprises said agonist and such product is used in the preparation of the composition for use in treating hyperlipidemia or reducing triacylglycerols, glycerol and cholesterol in a patient's body.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: April 11, 2006
    Assignee: Societe de Conseils de Recherches et d'Applications Scientifiques, SAS
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
  • Somatostatin and somatostatin agonists for treating insulin insensitivity and Syndrome X
    Publication number: 20040072734
    Abstract: The present invention relates to a method of treating insulin resistance or Syndrome X. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient. The invention also includes pharmaceutical compositions comprising a somatostatin or somatostatin agonist and the use of such products in the preparation of such compositions.
    Type: Application
    Filed: February 18, 2003
    Publication date: April 15, 2004
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt
  • METHOD AND COMPOSITIONS FOR TREATING HYPERLIPIDEMIA AND OTHER CONDITIONS
    Publication number: 20020151500
    Abstract: The present invention relates to a method of treating hyperlipidemia and to reducing triacylglycerols. glycerol and cholesterol in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to said patient. A pharmaceutical composition comprises said agonist and such product is used in the preparation of the composition for use in treating hyperlipidemia or reducing triacylglycerols, glycerol and cholesterol in a patient's body.
    Type: Application
    Filed: March 20, 2000
    Publication date: October 17, 2002
    Inventors: MICHAEL ANTHONY CAWTHORNE, YONG-LING LIU, MATTHEW V. SENNITT
  • METHOD OF TREATING INSULIN INSENSITIVITY AND SYNDROME X
    Publication number: 20020042374
    Abstract: The present invention relates to a method of treating insulin resistance or syndrome X in a patient. The method includes the step of administering a therapeutically effective amount of a somatostatin or a somatostatin agonist to said patient.
    Type: Application
    Filed: May 13, 1998
    Publication date: April 11, 2002
    Inventors: MICHAEL ANTHONY CAWTHORNE, YONG-LING LIU, MATTHEW V. SENNITT
  • Method of treating hyperlipidemia
    Patent number: 6004928
    Abstract: The present invention relates to a method of decreasing body weight in a patient. The method includes the step of administering a therapeutically effective amount of a type-5 selective somatostatin agonist to the patient.
    Type: Grant
    Filed: May 13, 1998
    Date of Patent: December 21, 1999
    Assignee: Biomeasure, Incorporated
    Inventors: Michael Anthony Cawthorne, Yong-Ling Liu, Matthew V. Sennitt